Institute Of Materia Medica And TB Alliance Announce Partnership To Develop New Tuberculosis Drugs
Thu, 01 Feb 2007 08:00 AM EST
... The Institute of Materia Medica (IMM), a member of the Chinese Academy of Medical Sciences, and the Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership accelerating the discovery and development of new TB drugs, today announced plans to pursue a joint research partnership to develop promising, novel anti-tuberculosis agents. [click link for full article] ...
Related Topics
- Tuberculosis
- Tb
- Tuberculosis/tb
- TB Skin Test
- Isoniazid
- Tuberculosis Vaccine
- A Partnership for Health: Minorities & Biomedical Research
- Tuberculosis Surveillance Reports
- Mycobacterium tuberculosis Infection
- Anticancer Drugs
- Date Rape Drugs
- Disease-modifying anti-rheumatoid drugs
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Naturopathy
- Pediatric Care
- Erectile Dysfunction
- Genomics & Disease Prevention
- Hypnotherapy
- Communication Disorders
- Functional medicine

Not Signed In -


